-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HLhm/C8rmemFwcdiRRejwlMdsg96xAQO9Hs/fRunJWruchfbXloEaVbJz10WgTZ2 hwUJpjerCJsDnTC5GY1OxA== 0001224334-04-000001.txt : 20040206 0001224334-04-000001.hdr.sgml : 20040206 20040206175648 ACCESSION NUMBER: 0001224334-04-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040204 FILED AS OF DATE: 20040206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FOREST LABORATORIES INC CENTRAL INDEX KEY: 0000038074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 111798614 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2124217850 MAIL ADDRESS: STREET 1: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CANDEE WILLIAM J III CENTRAL INDEX KEY: 0001224334 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-05438 FILM NUMBER: 04575473 BUSINESS ADDRESS: STREET 1: FOREST LABORATORIES STREET 2: 909 3RD AVE. CITY: NEW YORK STATE: NY ZIP: 10022 4 1 c0001224334d20040206f4f.xml PRIMARY DOCUMENT X0201 4 2004-02-04 0 0000038074 FOREST LABORATORIES INC FRX 0001224334 CANDEE WILLIAM J III C/O FOREST LABORATORIES 909 THIRD AVENUE NEW YORK NY 10022 1 0 0 0 Common Stock 2004-02-04 4 M 0 4500 4.6016 A 9183 D Common Stock 2004-02-04 4 M 0 1500 5.6368 A 10683 D Common Stock 2004-02-04 4 S 0 1500 0 D 9183 D Common Stock 2004-02-04 4 S 0 4500 0 D 4683 D Stock Options (Right to buy) 4.6016 2004-02-04 4 M 0 4500 0 D 1996-08-12 2006-08-12 Common Stock 4500 0 D Stock Options (Right to buy) 5.6368 2004-02-04 4 M 0 1500 0 D 1997-08-11 2007-08-11 Common Stock 1500 14500 D The reporting person beneficially owns 53,183 shares which includes options to purchase 48,500 shares. William J Candee, III 2004-02-06 -----END PRIVACY-ENHANCED MESSAGE-----